Press release
Increasing Autoimmune Disease Prevalence Drives Rheumatology Therapeutics Market Growth: Pivotal Factor Influencing Rheumatology Therapeutics Market Growth in 2025
Rheumatology Therapeutics
Rheumatology Therapeutics Market Size Growth Forecast: What to Expect by 2025?
The market for rheumatology therapeutics has seen robust growth in the recent past. The market size is expected to expand from $42.4 billion in 2024 to $44.61 billion in 2025, marking a compound annual growth rate (CAGR) of 5.2%. This surge during the historical period is influenced by factors such as an increase in rheumatologic disorders, a globally aging population, greater knowledge about available treatments, improvements in biological therapies, and the broadening of healthcare access in emerging markets.
How Will the Rheumatology Therapeutics Market Size Evolve and Grow by 2029?
The market for rheumatology therapeutics is anticipated to experience a consistent growth in the coming years, expanding to $53.88 billion by 2029 with a 4.8% compound annual growth rate (CAGR). This growth during the prediction period can be linked to the inclination towards personalized medicine strategies, the increasing acceptance of biosimilars in rheumatology, enhanced investment in R&D, incorporation of digital health technologies, and approval of new therapies by regulatory authorities. The forthcoming period will witness trends such as the expansion of telemedicine and remote monitoring solutions, development of targeted treatments for specific rheumatological conditions, focus on patient-centric care models, proliferation of biologic treatments beyond monoclonal antibodies, and the shift to value-based pricing models.
View the full report here:
https://www.thebusinessresearchcompany.com/report/rheumatology-therapeutics-global-market-report
What Drivers Are Propelling the Growth of Rheumatology Therapeutics Market Forward?
The increasing occurrence of autoimmune diseases is anticipated to accelerate the expansion of the rheumatology therapeutics market. Autoimmune diseases are conditions in which the immune system erroneously attacks and harms the body's tissues. The growing occurrence of these diseases can be attributed to genetic, environmental, and lifestyle factors, as well as enhanced awareness and diagnostic abilities. Therapies in rheumatology are crucial in treating autoimmune diseases as they control inflammation, relieve symptoms, and prevent damage to joints and tissues due to the immune system's attack on the body. For example, the Australian Institute of Health and Welfare reported in June 2024 that roughly 514,000 individuals in Australia, or 2.0% of the population, were projected to be suffering from rheumatoid arthritis in 2022. Rheumatoid arthritis was responsible for 2.0% of the overall disease load and 16% of the load for all musculoskeletal conditions in 2023. Hence, the increasing occurrence of autoimmune diseases is fueling the expansion of the rheumatology therapeutics market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=17246&type=smp
Which Emerging Trends Are Transforming the Rheumatology Therapeutics Market in 2025?
Leading enterprises in the rheumatology therapeutics industry are introducing groundbreaking solutions such as intravenous (IV) formulations to improve the effectiveness of treatments and the convenience for patients. An intravenous (IV) formulation involves the direct administration of medication or substance into a vein via a needle or catheter. For example, in October 2023, Switzerland-based Novartis AG, a leading pharmaceutical firm, revealed that its intravenous (IV) formulation, Cosentyx, had received approval from the US Food and Drug Administration (FDA). This particular version of Cosentyx is exclusively approved to treat adults suffering from psoriatic arthritis (PsA), ankylosing spondylitis (AS), and non-radiographic axial spondyloarthritis (nr-axSpA). In terms of mechanism, it specifically focuses on and inhibits interleukin-17A (IL-17A) and is the sole non-tumor necrosis factor alpha (TNF-a) IV treatment available for these ailments.
What Are the Key Segments in the Rheumatology Therapeutics Market?
The rheumatology therapeutics market covered in this report is segmented -
1) By Drug Class: Disease Modifying Anti-Rheumatic Drugs, Nonsteroidal Anti-Inflammatory Drugs, Corticosteroids, Uric Acid Drugs, Other Drugs Classes
2) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
3) By Disease Indication: Rheumatoid Arthritis, Osteoarthritis, Gout, Psoriatic Arthritis, Ankylosing Spondylitis, Other Disease Indications
Subsegments:
1) By Disease Modifying Anti-Rheumatic Drugs (DMARDs): Conventional Synthetic DMARDs, Biologic DMARDs, Targeted Synthetic DMARDs
2) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): COX-2 Inhibitors, Traditional NSAIDs
3) By Corticosteroids: Oral Corticosteroids, Injectable Corticosteroids, Topical Corticosteroids
4) By Uric Acid Drugs: Uric Acid Lowering Agents, Uricosuric Agents, Pegloticase
5) By Other Drug Classes: Immunosuppressants, Biologic Therapies, Analgesics
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=17246&type=smp
Who Are the Key Players Shaping the Rheumatology Therapeutics Market's Competitive Landscape?
Major companies operating in the rheumatology therapeutics market are Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis AG, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Boehringer Ingelheim International GmbH, Gilead Sciences Inc., Janssen Biotech, Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals, UCB S.A., Galapagos NV (GLPG), Genentech Inc.
What Geographic Markets Are Powering Growth in the Rheumatology Therapeutics Market?
North America was the largest region in the rheumatology therapeutics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rheumatology therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=17246
This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Increasing Autoimmune Disease Prevalence Drives Rheumatology Therapeutics Market Growth: Pivotal Factor Influencing Rheumatology Therapeutics Market Growth in 2025 here
News-ID: 4139508 • Views: …
More Releases from The Business Research Company
Percutaneous Puncture Surgery Robot Market Analysis Highlights Growth To $3.54 B …
The market for percutaneous puncture surgery robots is on the verge of significant expansion, driven by rapid technological advances and increasing adoption in healthcare settings. As robotic systems become more sophisticated and integrated with cutting-edge technologies, this sector is set to transform minimally invasive surgical procedures. Below is a detailed exploration of the market's size, key players, trends, and segmentation that shape its future trajectory.
Projected Growth and Market Size of…
Pedicle Screw Systems Market Study Highlights How Industry Demand Is Evolving
The pedicle screw systems market is set to experience significant expansion in the coming years, driven by advancements in spinal surgery techniques and increasing patient demand. This market's evolution reflects growing medical needs and ongoing innovation, positioning it for substantial growth by 2030.
Forecasted Market Size and Growth Trajectory for Pedicle Screw Systems
The value of the pedicle screw systems market is projected to reach $7.65 billion by 2030, growing…
Pediatric Orthopedic Implants Market Research Reveals Strong 10.8% CAGR Outlook …
The pediatric orthopedic implants market is on track for significant expansion as advancements in technology and growing healthcare needs drive demand. Innovations in implant design and personalized treatment options are setting the stage for transformative growth in this specialized segment of medical devices. Below is a detailed overview of the current market size, key industry players, emerging trends, and segmentation that define this market's future.
Pediatric Orthopedic Implants Market Size and…
Pediatric Interventional Cardiology Market Intelligence Report Covers Trends, Se …
The pediatric interventional cardiology field is on track for significant expansion, driven by advances in medical technology and growing demand for specialized cardiac care for children. This sector is expected to see dynamic growth as innovative devices and techniques become more widely adopted to improve patient outcomes.
Projected Market Size and Growth Trajectory of the Pediatric Interventional Cardiology Market
The market for pediatric interventional cardiology is forecasted to grow steadily,…
More Releases for Rheumatology
Understanding the Rheumatology Market: Segments & Scope
According to The Insight Partners, the rheumatology market is broadly segmented by:
• Drug class: nonsteroidal anti inflammatory drugs (NSAIDs), corticosteroids, uric acid drugs, and disease modifying anti rheumatic drugs (DMARDs).
• Disease indications: rheumatoid arthritis, osteoarthritis, gout, psoriatic arthritis, ankylosing spondylitis.
• Distribution channels: hospital pharmacies, retail pharmacies, online pharmacies.
• Geography: the usual regions (North America, Europe, Asia Pacific, South & Central America, etc.) with further country level breakdowns.
CAGR (Compound Annual Growth…
Rheumatology Therapeutics Market to Hit $59.1 Billion by 2030
◉ Global Rheumatology Therapeutics Market Set to Reach USD 59.1 Billion by 2030, Driven by Aging Population and Innovation
The global rheumatology therapeutics market is poised for steady growth, projected to reach nearly USD 59.1 billion by 2030, expanding at a CAGR of 2.7% from 2024 to 2030, according to Maximize Market Research. This growth is fueled by an aging global population, rising prevalence of rheumatic diseases, and continuous advancements in…
Rheumatology Therapeutics Market 2023 Driving Factors Forecast Research 2029
Rheumatology Therapeutics market is anticipated to grow at a CAGR of 3.2% during the forecast period (2023-2030). Therapeutic drugs are used to slow down the progression of certain autoimmune rheumatic diseases such as rheumatic arthritis (RA). The increasing prevalence of RA globally has bolstered the launch of novel therapeutic agents and favorable refurbishment policies for high-cost treatment products are some of the factors driving the market growth. According to the…
Current trends in Rheumatology, Orthopedics, and Arthroplasty
2nd International Conference on Rheumatology, Orthopedics and Arthroplasty
December 05-06, 2022 | Dubai, UAE
Theme: Current Trends in Rheumatology, Orthopedics and Arthroplasty
Rheumatology 2022 will provide an international platform for all Speakers, Delegates, Surgeons, Research Scholars, Orthopedic Physicians, Orthopedic Surgeons, Rheumatologists, Orthopedic and Rheumatology Research Fellows, Orthopedic and Rheumatology Faculty, Directors and Chair Persons, Health Care Professionals, Orthopedic and Rheumatology Medical Students, Orthopedics Medical Colleges, Universities, Orthopedics Devices Designers etc.
Audience Profile:
· …
Rheumatology Therapeutics Market
Global Rheumatology Therapeutics Market: Snapshot
A rising elderly population and increasing allocations for research and development of new drugs is what is serving to drive growth in the global rheumatology therapeutics market. This has led to the emergence of many new drugs. Their swift approvals by the appropriate authorities has also led to the growth in the market.
A report by Transparency Market Research uncovers after in-depth study that the global rheumatology…
Increasing burden of rheumatology diseases globally is propelling the growth of …
Rheumatology diseases affects the supporting or connecting structures of the body mostly joints, ligaments, muscles, tendons, and rarely some organs of the body. This disease is characterized by inflammation of joints and it affects spine in some types of rheumatology disease. There are more than 100 types of rheumatic disease. It is caused by various genetic and environmental factors, such as unhealthy diet and changing lifestyle, which can lead to…
